Business
Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide
Outperforming NAD+ IV, Niagen IV (patented nicotinamide riboside or NR) provides superior tolerability, a 75% shorter infusion time, and increases NAD+ 20%
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":"\nOutperforming NAD+ IV, Niagen IV (patented nicotinamide riboside or NR) provides superior tolerability, a 75% shorter infusion time, and increases NAD+ 20% higher three hours post-infusion\n\n LOS ANGELES--(BUSINESS WIRE)--\nNiagen Bioscience, Inc. (Nasdaq: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the continued expansion of its clinical footprint with additional new clinics now offering pharmaceutical-grade Niagen® IV and injections featuring patented nicotinamide riboside. These new providers join a growing network of almost 600 clinics nationwide offering the first-of-its-kind, pharmaceutical-grade NAD-boosting Niagen IV therapy. For a list of all clinic providers, please visit https://www.niagenplus.com/pages/clinic-locator.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505444041/en/Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide\nRob Fried, CEO of Niagen Bioscience, stated, “At the heart of the Niagen Plus ecosystem are our sterile pharmaceutical-grade Niagen NR formulations for IV as well as intramuscular (IM) and subcutaneous (SubQ) injections. These Niagen NR products are high-quality solutions for those seeking the most advanced, clinically supported NAD-boosting interventions.”\n\nSome of the new clinic providers include:\n\n\nArete (Nashville, TN)\n\n\nBeautologie (Bakersfield, CA)\n\n\nBeyond Remedi (Saint Paul, MN)\n\n\nClarus Health (San Francisco, CA)\n\n\nPEAQ Society (Kansas City, MO)\n\n\nEnergy4Life Centers (Park City, UT)\n\n\nHydra Heal (Newport Beach, CA)\n\n\nKahala Clinic (Honolulu, HI)\n\n\nLifeMed Institute (BelAir, MD; Columbia, MD; Rehoboth Beach, DE; Timonium, MD)\n\n\nLongevity LA (Los Angeles, CA)\n\n\nNavo (New York, NY)\n\n\nOutperforming NAD+ IV, Niagen IV is a significant advancement in NAD-boosting therapy. In a head-to-head comparison with NAD+ IV, Niagen IV offers superior tolerability, a 75% shorter infusion time, and a statistically significant 20% increase in whole blood NAD+ levels three hours after infusion, as measured by NAD+ dried blood spot tests (MedRxiv). Study results demonstrated that NAD+ IV had a longer infusion time and was associated with a high prevalence ...